StonvexLoading…
StonvexStonvexStonvexCore line items from DT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|---|
Revenue | $569.21M | $1.49B | $971.20M | $477.35M | $1.70B |
Operating Income | Not available | $208.04M | $135.31M | $62.34M | $179.43M |
Net Income | Not available | $145.25M | $105.20M | $47.95M | $483.68M |
EPS (Diluted) | $0.47 | $0.48 | $0.35 | $0.16 | $1.59 |
Total Assets | Not available | $4.10B | $4.08B | $4.08B | $4.14B |
Total Liabilities | Not available | $1.35B | $1.30B | $1.38B | $1.52B |
Cash & Equivalents | Not available | $1.09B | $1.23B | $1.25B | $1.02B |
Free Cash Flow OCF − CapEx | Not available | $317.27M | $290.04M | $262.21M | $433.31M |
Shares Outstanding | Not available | 299.57M | 301.79M | 301.72M | 299.81M |